US 8809292
Compositions and methods for inhibiting expression of the PCSK9 gene
granted A61KA61K31/713A61P
Quick answer
US patent 8809292 (Compositions and methods for inhibiting expression of the PCSK9 gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 38
- CPC classes
- A61K, A61K31/713, A61P, A61P3/06, A61P43/00